Gulveen Aulakh And Sanket Koul

Stories by Gulveen Aulakh And Sanket Koul

Offers Pour In At IITs' Placement Season

Offers Pour In At IITs' Placement Season

Rediff.com   24 Dec 2024

Major recruiters, with double-digit offers at IIT campuses this year so far, include American Express, Barclays, BCG, Cars24, Deutsche Bank, Goldman Sachs, Google, Intel India, Meesho, Micron Technology, Microsoft, OLA, Oracle, Reliance, and Qualcomm.

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com   9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

Half of India Faces Glucose Imbalance

Half of India Faces Glucose Imbalance

Rediff.com   5 Dec 2024

'Obesity, especially central obesity and increased visceral fat due to physical inactivity, along with the consumption of high-calorie, high-fat, and high-sugar diets, are major contributing factors.'

AQI Spike Triggers Health Crisis

AQI Spike Triggers Health Crisis

Rediff.com   20 Nov 2024

'Many of these patients arrive at emergency departments in distress, struggling to breathe and requiring immediate medical intervention.'

What's Driving Surge in Breast Cancer?

What's Driving Surge in Breast Cancer?

Rediff.com   1 Nov 2024

Late-stage diagnosis is a major issue, with over 75 per cent of cases being detected at advanced stages (50 per cent at Stage 3 and 25 per cent at Stage 4). This significantly reduces survival rates.

Mpox Puts Health System On High Alert

Mpox Puts Health System On High Alert

Rediff.com   17 Aug 2024

Strict screening protocols are to be implemented for passengers arriving from central African countries affected by the outbreak.

Mankind Pharma to lead in Indian women's health market after BSV deal

Mankind Pharma to lead in Indian women's health market after BSV deal

Rediff.com   29 Jul 2024

New Delhi-based pharmaceutical major Mankind Pharma is poised to take pole position in women's health portfolio in the India Pharma Market (IPM) after completing the Rs 13,630 crore deal to acquire Bharat Serums and Vaccines (BSV), senior company officials said. The deal potentially opens doors for Mankind Pharma to the overseas markets, which currently draws 92 per cent of its revenues from India. The combined entity will draw around 13 per cent revenues from the international market, with the remaining coming from the domestic market.

Now, Karnataka Wants To Scrap NEET

Now, Karnataka Wants To Scrap NEET

Rediff.com   26 Jul 2024

Karnataka has the highest number of medical seats in the country at 11,745, of which 3,750 seats were in government institutions and 7,995 seats were in private colleges.

Even MBAs Find It Tough To Get Jobs

Even MBAs Find It Tough To Get Jobs

Rediff.com   1 Jul 2024

'Corporations that were recruiting 15 or 20 [students] have reduced the number to two or three.'

How To Fix Ayushman Bharat: Experts To FM

How To Fix Ayushman Bharat: Experts To FM

Rediff.com   28 Jun 2024

'Patients under the scheme may ultimately have to go to private hospitals.'

NEET-PG Delay May Push Doctors Abroad

NEET-PG Delay May Push Doctors Abroad

Rediff.com   24 Jun 2024

'The NEET-PG is the only exam for admission to MD, MS and PG Diploma courses.' 'Many doctors take time off from work to prepare for it, while others study during their long hospital shifts.'

52% Of Urban Indians Utilise Ayush

52% Of Urban Indians Utilise Ayush

Rediff.com   18 Jun 2024

Ayush refers to the six Indian systems of medicines, namely Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homeopathy are majorly prevalent in the country.

Expanding Ayushman Bharat On Cards

Expanding Ayushman Bharat On Cards

Rediff.com   15 Jun 2024

The move to expand the health insurance scheme's coverage comes at a time when several hospitals have complained of delays in reimbursement related to the procedures performed under the scheme.

Modi 3.0's Plans For Ayushman Bharat

Modi 3.0's Plans For Ayushman Bharat

Rediff.com   12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat scheme to Rs 10 lakh from the current Rs 5 lakh.

'Fortis plans to add 700 beds in FY25'

'Fortis plans to add 700 beds in FY25'

Rediff.com   12 Jun 2024

'Our priority remains brownfield expansion, and in the next few years, we plan to increase our capacity to around 6,000 beds.'

Frontline Relive Pandemic Nightmare

Frontline Relive Pandemic Nightmare

Rediff.com   1 Apr 2024

Battling the virus, enduring separation from loved ones, and working extended hours became part of the job.

Want To Buy A Bungalow For Rs 325 Crore?

Want To Buy A Bungalow For Rs 325 Crore?

Rediff.com   1 Mar 2024

Enquiries indicate it belongs to an industrialist with links to a prominent cricketer.

AyushMin gets rap for underuse of funds despite rising allocation

AyushMin gets rap for underuse of funds despite rising allocation

Rediff.com   27 Feb 2024

Given the gap between budgetary allocation and use, a parliamentary standing committee has asked the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (Ayush) to take steps to prevent underutilisation of funds under the National Ayush Mission (NAM) scheme. According to the data, the ministry was allocated Rs 1,200 crore for the mission in the Budgetary Estimate (BE) for FY24. The Revised Estimate (RE) for the year fell to Rs 815 crore, of which Rs 589 crore, or 74 per cent, has been spent till January.

Revised Schedule M elicits mixed response

Revised Schedule M elicits mixed response

Rediff.com   8 Jan 2024

A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.

Are hospitals ready to handle Covid surge?

Are hospitals ready to handle Covid surge?

Rediff.com   26 Dec 2023

Larger hospitals are not worried about a spike in cases, as they are now accustomed to converting ICUs and general wards into negative pressure zones or isolation rooms. For smaller hospitals, the task is tedious.